Jean-Michel Vix
Boehringer Ingelheim
16 Papers
47 Citations
Jean-Michel Vix is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Ambroxol & Placebo. The author has an hindex of 8, co-authored 15 publications.
Chat about Author
Papers
Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial.
Holger Kiesewetter,Jürgen Koscielny,Ulrich Kalus,Jean-Michel Vix,Hubertus Peil,Orlando Petrini,B. S. J. Van Toor,C. De Mey +7 more
TL;DR: Once-daily doses of 360 and 720 mg AS 195 were confirmed to be safe and effective in the treatment of mild CVI, reducing significantly lower leg edema and circumference.
104
Efficacy and safety of bisacodyl in the acute treatment of constipation: a double‐blind, randomized, placebo‐controlled study
TL;DR: Although laxatives are a first‐line treatment for constipation, there are few randomized placebo‐controlled trials assessing their efficacy and the quality of these trials is still under investigation.
87
Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation
Susanne Kienzle-Horn,Jean-Michel Vix,Chris Schuijt,Hubertus Peil,C. C. Jordan,Michael A. Kamm +5 more
TL;DR: Bisacodyl and sodium picosulphate are equally well tolerated and effective in the treatment of chronic constipation over a 4-week period, providing sustained improvement in symptoms.
63
Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. EBM-based clinical documentation.
TL;DR: It is concluded that lozenges containing 20 mg ambroxol are a safe and efficacious treatment for acute uncomplicated sore throat of recent onset in adult patients.
40
Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials regarding the local anaesthetic properties.
Jürgen Fischer,Uwe Pschorn,Jean-Michel Vix,Hubertus Peil,Bernhard Aicher,Achim Müller,Christian de Mey +6 more
TL;DR: Sucking lozenges containing 20 mg or 30 mg ambroxol hydrochloride has a beneficial pain-relieving effect in patients with acute sore throat, superior to that achieved by sucking a placebo lozenge, according to patients' evaluation of efficacy and tolerability at the end of each day of the three days treatment.
38